DLQI as a major criterion for introduction of systemic agents in patients with mild psoriasis
暂无分享,去创建一个
[1] A. Finlay,et al. Dermatology Life Quality Index (DLQI) as a psoriasis referral triage tool , 2017, The British journal of dermatology.
[2] J. Hendriks,et al. A pilot study on the Psoriasis Area and Severity Index (PASI) for small areas: Presentation and implications of the Low PASI score , 2015, The Journal of dermatological treatment.
[3] M. Eriksson,et al. Decision for biological treatment in real life is more strongly associated with the Psoriasis Area and Severity Index (PASI) than with the Dermatology Life Quality Index (DLQI) , 2015, Journal of the European Academy of Dermatology and Venereology : JEADV.
[4] G. Trajkovic,et al. Identification of psoriatic patients at risk of high quality of life impairment , 2013, The Journal of dermatology.
[5] G. Schmid‐Ott,et al. Perceived relationships between severity of psoriasis symptoms, gender, stigmatization and quality of life , 2013, Journal of the European Academy of Dermatology and Venereology : JEADV.
[6] G. Nocea,et al. Validation of a new tool to assess health-related quality of life in psoriasis: the PSO-LIFE questionnaire , 2012, Health and Quality of Life Outcomes.
[7] M. Otuki,et al. Patient‐reported outcomes in psoriasis research and practice , 2011, The British journal of dermatology.
[8] C. Griffiths,et al. Definition of treatment goals for moderate to severe psoriasis: a European consensus , 2010, Archives of Dermatological Research.
[9] Jan D Bos,et al. How good are clinical severity and outcome measures for psoriasis?: quantitative evaluation in a systematic review. , 2010, The Journal of investigative dermatology.
[10] F. Aubin,et al. What are the best outcome measures for assessing quality of life in plaque type psoriasis? A systematic review of the literature , 2010, Journal of the European Academy of Dermatology and Venereology : JEADV.
[11] M. Augustin,et al. Concordance of the Psoriasis Area and Severity Index (PASI) and patient-reported outcomes in psoriasis treatment. , 2010, European journal of dermatology : EJD.
[12] W. Sterry,et al. Do guidelines change the way we treat? Studying prescription behaviour among private practitioners before and after the publication of the German Psoriasis Guidelines , 2009, Archives of Dermatological Research.
[13] A. Finlay,et al. Clinical management decisions are related to the impact of psoriasis on patient‐rated quality of life , 2005, The British journal of dermatology.
[14] D M Reboussin,et al. Psoriasis causes as much disability as other major medical diseases. , 1999, Journal of the American Academy of Dermatology.
[15] A. Finlay,et al. Dermatology Life Quality Index (DLQI)—a simple practical measure for routine clinical use , 1994, Clinical and experimental dermatology.
[16] T Fredriksson,et al. Severe psoriasis--oral therapy with a new retinoid. , 1978, Dermatologica.